Apyx Medical (APYX) Other Non-Current Liabilities (2010 - 2026)
Apyx Medical (APYX) posted Other Non-Current Liabilities of $339000.0 for Q1 2026, down 2.31% on a QoQ basis from $347000.0 in Q4 2025, and up 25.56% year-over-year from $270000.0 in Q1 2025.
Apyx Medical (APYX) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends
Apyx Medical's Other Non-Current Liabilities history runs 17 years deep, the most recent figure standing at $339000.0 for Q1 2026.
- Quarterly Other Non-Current Liabilities rose 25.56% year-over-year to $339000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $339000.0 (up 25.56% YoY) and the FY2025 annual result came in at $347000.0, up 33.98% from the prior year.
- Other Non-Current Liabilities was $339000.0 for Q1 2026 at Apyx Medical, down from $347000.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $347000.0 in Q4 2025 and bottomed at $133000.0 in Q3 2022.
- A 5-year average of $220176.5 and a median of $194000.0 in 2024 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2022 — Other Non-Current Liabilities dropped 8.9% — and 2025, when it jumped 52.08%.
- Apyx Medical's Other Non-Current Liabilities stood at $181000.0 in 2022, then climbed by 9.39% to $198000.0 in 2023, then jumped by 30.81% to $259000.0 in 2024, then jumped by 33.98% to $347000.0 in 2025, then fell by 2.31% to $339000.0 in 2026.
- Business Quant data shows APYX's Other Non-Current Liabilities at $339000.0 in Q1 2026, $347000.0 in Q4 2025, and $293000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Apyx Medical | 170.16 Mn | 139.02 Mn | 7.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 339,000.00 |
| Dec 31, 2025 | 347,000.00 |
| Sep 30, 2025 | 293,000.00 |
| Jun 30, 2025 | 292,000.00 |
| Mar 31, 2025 | 270,000.00 |
| Dec 31, 2024 | 259,000.00 |
| Sep 30, 2024 | 201,000.00 |
| Jun 30, 2024 | 192,000.00 |
| Mar 31, 2024 | 194,000.00 |
| Dec 31, 2023 | 198,000.00 |
| Sep 30, 2023 | 181,000.00 |
| Jun 30, 2023 | 185,000.00 |
| Mar 31, 2023 | 185,000.00 |
| Dec 31, 2022 | 181,000.00 |
| Sep 30, 2022 | 133,000.00 |
| Jun 30, 2022 | 142,000.00 |
| Mar 31, 2022 | 151,000.00 |
| Dec 31, 2021 | 166,000.00 |
| Sep 30, 2021 | 146,000.00 |
| Jun 30, 2021 | 145,000.00 |